Efficacy and Safety of HIFU in Improving Bladder Control in Women with Urinary Incontinence

Introduction: Urinary incontinence is a common gynecological issue, affecting millions of women worldwide due to the weakening of pelvic floor muscles. Aims & Objectives: To evaluate the efficacy and safety of High-Intensity Focused Ultrasound (HIFU) for strengthening pelvic floor muscles and improving bladder control in women with urinary incontinence. Place and Duration of Study: The study was conducted at CMH Multan from April 2023 to May 2024 in collaboration with the gynecology and urology departments. Material & Methods: The current non-randomized trial included 100 females diagnosed with urinary incontinence and aged ?35 years through non-probability convenience sampling. This study adopted a unique HIFU treatment consisting of weekly 20-minute sessions over 8 consecutive weeks. The primary outcome was a change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score. Secondary outcomes included a reduction in incontinence episodes, bladder control parameters (maximum bladder capacity and detrusor pressure), strengthening pelvic floor (perineometry, digital palpation), life quality (I-QOL and PFDI-20), and adverse events. Descriptive statistics were expressed using SPSS version 23.0, as mean ± SD or frequency/percentages to check the mean difference across the two groups, t-test was applied. A p-value of <0.05 was considered statistically significant. Results: The HIFU group showed a significant decrease in ICIQ-UI SF scores (-6 ± 2) compared to the non-HIFU group (-2 ± 1, p < 0.001). HIFU participants experienced a greater decrease in incontinence episodes (10 ± 3 vs. 4 ± 2, p< 0.001) and improvements in bladder control and muscle strength. Participants undergoing HIFU demonstrated a significant rise in the I-QOL score (p < 0.01), with 80% reporting subjective improvement. The HIFU group also experienced minimal adverse effects and the results were significant. P<0.05. Conclusion: HIFU is an effective, safe, and non-invasive treatment for urinary incontinence, significantly improving symptoms, bladder control, muscle strength, and life quality while offering minimum to no adverse effects.

Authors

Institutions

Publication Details

Journal
Proceedings of Shaikh Zayed Medical Complex Lahore
Published
2025-03-24
DOI
https://doi.org/10.47489/szmc.v39i1.576
Citations
1
Primary Topic
Pelvic floor disorders treatments
Type
article
Field-Weighted Citation Impact
1.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of HIFU in Improving Bladder Control in Women with Urinary Incontinence

Sana Rauf, Sampana Fatima, Adeel Saleem, Shagufta Awais et al.
1 citations
Proceedings of Shaikh Zayed Medical Complex Lahore
Pelvic floor disorders treatments
1.67
article

Efficacy and Safety of HIFU in Improving Bladder Control in Women with Urinary Incontinence

Sana Rauf, Sampana Fatima, Adeel Saleem, Shagufta Awais, Saadia Kanwal, Wajeeha Imam
article en
1 citations

Abstract

Introduction: Urinary incontinence is a common gynecological issue, affecting millions of women worldwide due to the weakening of pelvic floor muscles. Aims & Objectives: To evaluate the efficacy and safety of High-Intensity Focused Ultrasound (HIFU) for strengthening pelvic floor muscles and improving bladder control in women with urinary incontinence. Place and Duration of Study: The study was conducted at CMH Multan from April 2023 to May 2024 in collaboration with the gynecology and urology departments. Material & Methods: The current non-randomized trial included 100 females diagnosed with urinary incontinence and aged ?35 years through non-probability convenience sampling. This study adopted a unique HIFU treatment consisting of weekly 20-minute sessions over 8 consecutive weeks. The primary outcome was a change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score. Secondary outcomes included a reduction in incontinence episodes, bladder control parameters (maximum bladder capacity and detrusor pressure), strengthening pelvic floor (perineometry, digital palpation), life quality (I-QOL and PFDI-20), and adverse events. Descriptive statistics were expressed using SPSS version 23.0, as mean ± SD or frequency/percentages to check the mean difference across the two groups, t-test was applied. A p-value of <0.05 was considered statistically significant. Results: The HIFU group showed a significant decrease in ICIQ-UI SF scores (-6 ± 2) compared to the non-HIFU group (-2 ± 1, p < 0.001). HIFU participants experienced a greater decrease in incontinence episodes (10 ± 3 vs. 4 ± 2, p< 0.001) and improvements in bladder control and muscle strength. Participants undergoing HIFU demonstrated a significant rise in the I-QOL score (p < 0.01), with 80% reporting subjective improvement. The HIFU group also experienced minimal adverse effects and the results were significant. P<0.05. Conclusion: HIFU is an effective, safe, and non-invasive treatment for urinary incontinence, significantly improving symptoms, bladder control, muscle strength, and life quality while offering minimum to no adverse effects.

Proceedings of Shaikh Zayed Medical Complex LahoreVol. 39(1)
ASTER (CA), Government Sadiq College Women University (PK), Alhamd Islamic University (PK), Bahawal Victoria Hospital (PK)
Openalex Percentile: Top 19%
Pelvic floor disorders treatments
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.